Skip to content

(Cost-) Effectivity of a personalized e-health intervention for patients with psychiatric disorders on waiting lists for treatment- a randomized controlled trial.

(Cost-) Effectivity of a personalized e-health intervention for patients with psychiatric disorders on waiting lists for treatment- a randomized controlled trial. - The Wait time Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57243
Enrollment
408
Registered
2024-08-29
Start date
2025-03-31
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mental illness psychological complaints mental health problems

Interventions

The intervention arm will receive online access to a selection of existing online eHealth modules provided by Therapieland. Personalization will be achieved by employing both innovative and traditio

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A subject must: - be referred to mental healthcare (GGZ) and awaiting intake - be at least 18 years old - provide written informed consent - be able to read proficiently in the language the e-health module is offered  in (i.e. Dutch, or English)

Exclusion criteria

Exclusion criteria: - Participants who do not have access to a smartphone, tablet, computer, or  laptop - Participants who lack the necessary computer skills to complete e-health  modules - Patients referred to mental healthcare departments for psychotic disorders, mild intellectual disabilities, specialized eating disorder facilities or acute mental healthcare (*crisisdienst*)

Design outcomes

Primary

MeasureTime frame
Difference in the slope of symptom severity change over time, measured by the Symptom Questionnaire-48, during the waiting period (between referral and intake) between the intervention group and the control group

Secondary

MeasureTime frame
Secondary endpoints are cost-effectiveness, quality of life, intake efficiency, effects on digital phenotyping, satisfaction and acceptability.

Countries

Netherlands

Contacts

Public ContactA.N. Nelissen

Leids Universitair Medisch Centrum

a.n.nelissen@lumc.nl0715263785

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 19, 2026